BACKGROUND: Chemerin was recently introduced as a novel adipokine playing a crucial role in adipocyte differentiation and insulin signaling. In the current study, we investigated circulating chemerin levels in patients with gestational diabetes mellitus (GDM) as compared to healthy pregnant controls matched for gestational age and fasting insulin. METHODS: Chemerin was quantified by ELISA in control (n = 80) and GDM (n = 40) patients and correlated to clinical and biochemical measures of renal function, glucose and lipid metabolism, as well as inflammation, in both groups. RESULTS: Median maternal serum chemerin concentrations were not significantly different in subjects with GDM (230.3 microg/l) as compared to healthy pregnant controls (217.6 microg/l). Chemerin significantly and positively correlated with homeostasis model assessment of insulin resistance (HOMA-IR) and serum creatinine in uni- and multivariate analyses. Furthermore, chemerin serum levels were highest in patients in the third tertile of HOMA-IR. CONCLUSIONS: Chemerin is independently associated with markers of insulin resistance and renal dysfunction but is not dysregulated in GDM if patients are matched with controls for fasting insulin. Copyright 2010 S. Karger AG, Basel.
BACKGROUND:Chemerin was recently introduced as a novel adipokine playing a crucial role in adipocyte differentiation and insulin signaling. In the current study, we investigated circulating chemerin levels in patients with gestational diabetes mellitus (GDM) as compared to healthy pregnant controls matched for gestational age and fasting insulin. METHODS:Chemerin was quantified by ELISA in control (n = 80) and GDM (n = 40) patients and correlated to clinical and biochemical measures of renal function, glucose and lipid metabolism, as well as inflammation, in both groups. RESULTS: Median maternal serum chemerin concentrations were not significantly different in subjects with GDM (230.3 microg/l) as compared to healthy pregnant controls (217.6 microg/l). Chemerin significantly and positively correlated with homeostasis model assessment of insulin resistance (HOMA-IR) and serum creatinine in uni- and multivariate analyses. Furthermore, chemerin serum levels were highest in patients in the third tertile of HOMA-IR. CONCLUSIONS:Chemerin is independently associated with markers of insulin resistance and renal dysfunction but is not dysregulated in GDM if patients are matched with controls for fasting insulin. Copyright 2010 S. Karger AG, Basel.
Authors: Lei Zhao; Yasuto Yamaguchi; Shadi Sharif; Xiao-Yan Du; Jason J Song; David M Lee; Lawrence D Recht; William H Robinson; John Morser; Lawrence L K Leung Journal: J Biol Chem Date: 2011-09-19 Impact factor: 5.157
Authors: Matthew C Ernst; Ian D Haidl; Luis A Zúñiga; Helen J Dranse; Jillian L Rourke; Brian A Zabel; Eugene C Butcher; Christopher J Sinal Journal: Endocrinology Date: 2011-12-20 Impact factor: 4.736
Authors: Rafael González-Alvarez; María de Lourdes Garza-Rodríguez; Iván Delgado-Enciso; Víctor Manuel Treviño-Alvarado; Ricardo Canales-Del-Castillo; Laura Elia Martínez-De-Villarreal; Ángel Lugo-Trampe; María Elizabeth Tejero; Natalia E Schlabritz-Loutsevitch; María Del Refugio Rocha-Pizaña; Shelley A Cole; Diana Reséndez-Pérez; Mario Moises-Alvarez; Anthony G Comuzzie; Hugo Alberto Barrera-Saldaña; Raquel Garza-Guajardo; Oralia Barboza-Quintana; Irám Pablo Rodríguez-Sánchez Journal: Biol Res Date: 2015-06-12 Impact factor: 5.612
Authors: Anke Tönjes; Markus Scholz; Jana Breitfeld; Carola Marzi; Harald Grallert; Arnd Gross; Claes Ladenvall; Dorit Schleinitz; Kerstin Krause; Holger Kirsten; Esa Laurila; Jennifer Kriebel; Barbara Thorand; Wolfgang Rathmann; Leif Groop; Inga Prokopenko; Bo Isomaa; Frank Beutner; Jürgen Kratzsch; Joachim Thiery; Mathias Fasshauer; Nora Klöting; Christian Gieger; Matthias Blüher; Michael Stumvoll; Peter Kovacs Journal: PLoS Genet Date: 2014-12-18 Impact factor: 5.917